Bio-Techne Corp (TECH)
62.12
-0.12
(-0.18%)
USD |
NASDAQ |
Apr 19, 16:00
62.12
0.00 (0.00%)
After-Hours: 16:48
Bio-Techne Free Cash Flow: 225.39M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | 225.39M |
September 30, 2023 | 215.42M |
June 30, 2023 | 216.15M |
March 31, 2023 | 232.73M |
December 31, 2022 | 251.98M |
September 30, 2022 | 284.52M |
June 30, 2022 | 280.36M |
March 31, 2022 | 301.92M |
December 31, 2021 | 308.16M |
September 30, 2021 | 295.16M |
June 30, 2021 | 307.86M |
March 31, 2021 | 224.58M |
December 31, 2020 | 200.50M |
September 30, 2020 | 178.53M |
June 30, 2020 | 153.47M |
March 31, 2020 | 170.31M |
December 31, 2019 | 164.86M |
September 30, 2019 | 150.96M |
June 30, 2019 | 156.21M |
March 31, 2019 | 170.98M |
December 31, 2018 | 154.38M |
September 30, 2018 | 145.27M |
June 30, 2018 | 149.43M |
March 31, 2018 | 135.39M |
December 31, 2017 | 138.25M |
Date | Value |
---|---|
September 30, 2017 | 144.18M |
June 30, 2017 | 128.54M |
March 31, 2017 | 117.16M |
December 31, 2016 | 130.45M |
September 30, 2016 | 125.33M |
June 30, 2016 | 127.26M |
March 31, 2016 | 123.87M |
December 31, 2015 | 115.42M |
September 30, 2015 | 114.35M |
June 30, 2015 | 119.45M |
March 31, 2015 | 125.07M |
December 31, 2014 | 129.89M |
September 30, 2014 | 124.98M |
June 30, 2014 | 122.94M |
March 31, 2014 | 111.76M |
December 31, 2013 | 107.74M |
September 30, 2013 | 103.13M |
June 30, 2013 | 101.11M |
March 31, 2013 | 112.75M |
December 31, 2012 | 118.97M |
September 30, 2012 | 114.14M |
June 30, 2012 | 120.73M |
March 31, 2012 | 117.85M |
December 31, 2011 | 116.77M |
September 30, 2011 | 127.25M |
Free Cash Flow Range, Past 5 Years
150.96M
Minimum
Sep 2019
308.16M
Maximum
Dec 2021
227.32M
Average
224.58M
Median
Mar 2021
Free Cash Flow Benchmarks
Agilent Technologies Inc | 1.649B |
Bio-Rad Laboratories Inc | 218.26M |
Revvity Inc | 9.904M |
Twist Bioscience Corp | -128.84M |
AIM ImmunoTech Inc | -21.85M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 83.12M |
Cash from Investing (Quarterly) | -23.67M |
Cash from Financing (Quarterly) | -81.40M |
Free Cash Flow Per Share (Quarterly) | 0.4264 |
Free Cash Flow to Equity (Quarterly) | 61.25M |
Free Cash Flow to Firm (Quarterly) | 71.14M |
Free Cash Flow Yield | 2.25% |